Position in ENTA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$30,791
-$7,656 QoQ
Shares Held
2,438
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $3,031,079,822 across 242 Biotechnology names. ENTA ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,955,764 | $873,326,855 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
732,054 | $565,614,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
934,881 | $309,324,075 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,362,872 | $161,316,968 | |
| 5 | INCY |
Incyte Corp
|
1,543,188 | $145,244,853 | |
| 6 | INSM |
INSMED Inc
|
787,079 | $128,703,157 | |
| 7 | ARGX |
Argenx SE
|
150,850 | $110,158,211 | |
| 8 | MRNA |
Moderna, Inc.
|
750,841 | $38,142,721 |
All Filings in ENTA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,791 | 2,438 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $38,447 | 2,438 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $20,396 | 1,704 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $14,878 | 1,968 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $10,863 | 1,968 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,316 | 1,968 | Shares | Defined | 2025-02-13 | |
| 2024-06-30 | $21,906 | 1,689 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $30,415 | 1,742 | Shares | Defined | 2024-07-01 | |
| 2023-12-31 | $25,387 | 2,698 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $137,826 | 12,339 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,178,861 | 55,087 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,266,337 | 56,042 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,622,890 | 56,382 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,851,708 | 54,978 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,611,714 | 55,251 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $3,927,854 | 55,182 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,125,312 | 55,166 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,860,609 | 50,354 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,050,468 | 46,591 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,898,485 | 58,769 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,439,273 | 57,940 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $2,647,365 | 57,828 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,685,280 | 53,481 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,636,815 | 51,270 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||